Exogenous alpha 1-antitrypsin down-regulates SERPINA1 expression

The main goal of the therapy with purified human plasma alpha1-antitrypsin (A1AT) is to increase A1AT levels and to prevent lungs from elastolytic activity in patients with PiZZ (Glu(342)Lys) A1AT deficiency-related emphysema. Potential hepatic gains of this therapy are unknown. Herein, we investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Karadagi, Ahmad, Johansson, Helene, Zemack, Helen, Salipalli, Sandeep, Mörk, Lisa-Mari, Kannisto, Kristina, Jorns, Carl, Gramignoli, Roberto, Strom, Stephen, Stokkeland, Knut, Ericzon, Bo-Göran, Jonigk, Danny, Janciauskiene, Sabina, Nowak, Greg, Ellis, Ewa C. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423693/
https://www.ncbi.nlm.nih.gov/pubmed/28486562
http://dx.doi.org/10.1371/journal.pone.0177279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423693/
https://www.ncbi.nlm.nih.gov/pubmed/28486562
http://dx.doi.org/10.1371/journal.pone.0177279

Ejemplares similares